4th Quarter - Termination

THE CHARLES GROUP, LLC for HIGHLAND PHARMACEUTICALS, LLC

Firm
Client
Income
$10,000
Expenses
—
Terminated
Dec 31, 2012

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 14, 2013 $10,000 Replaced
4th Quarter - Termination (this page) Apr 11, 2013 $10,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

treatment of nonconvertible pharmaceutical products under US counternarcotics laws

LobbyistCovered position, as disclosed
BEN BAWDEN —
NELSON O BUNN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Justice, Dept of (DOJ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.